Daré Bioscience Investor Relations Material
Latest events
Q1 2025
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative products for women’s health. The company’s portfolio includes therapies aimed at addressing unmet needs in contraception, fertility, and sexual health. Daré’s products are designed to improve options for women by offering novel solutions in areas such as hormone-free contraception and treatments for female sexual disorders. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
DARE
Country
🇺🇸 United States